Broadfin Capital’s ChemoCentryx CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
GCM
AG
Broadfin Capital's CCXI Position: Q4 2014 in Review
Broadfin Capital sold out of ChemoCentryx (CCXI) in Q4 2014, closing a stake of 800,000 shares — an estimated $3.6M sold.
Broadfin Capital first reported a position in CCXI in Q4 2013 and held it in 4 quarters. The position peaked at $6.96M in Q1 2014. 65 funds tracked by Wall St. Rank hold CCXI as of Q4 2014.
- Broadfin Capital reported no remaining ChemoCentryx position as of Q4 2014 after selling out during the quarter.
- Broadfin Capital sold 800,000 ChemoCentryx shares in Q4 2014, an estimated $3.6M.
- Broadfin Capital first reported a position in ChemoCentryx in Q4 2013 and held it in 4 quarters.
- Broadfin Capital's ChemoCentryx position peaked at $6.96M in Q1 2014.
- 65 funds tracked by Wall St. Rank held ChemoCentryx as of Q4 2014.
Based on Broadfin Capital's 13F filing for Q4 2014, filed 17 Feb 2015.